Home
Conditions
Noncontiguous Stage II Grade 1 Follicular Lymphoma

Clinical trial condition

Noncontiguous Stage II Grade 1 Follicular Lymphoma

Explore clinical trials studying Noncontiguous Stage II Grade 1 Follicular Lymphoma. Study availability and eligibility vary by location and protocol.

22 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Noncontiguous Stage II Grade 1 Follicular Lymphoma trial results

Completed

Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer

NCT00112593

Conditions: AIDS-related Diffuse Large Cell Lymphoma, AIDS-related Diffuse Mixed Cell Lymphoma, AIDS-related Diffuse Small Cleaved Cell Lymphoma, +281 more
Locations: Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

Ondansetron in Preventing Nausea and Vomiting in Patients Undergoing Stem Cell Transplant

NCT00795769

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adnexal Diseases, Adult Acute Lymphoblastic Leukemia in Remission, +202 more
Locations: Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

Rituximab and Dexamethasone in Treating Patients With Low-Grade Non-Hodgkin Lymphoma

NCT00244855

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Contiguous Stage II Grade 1 Follicular Lymphoma, +40 more
Locations: Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

Lithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem Cell Transplant

NCT00408681

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adnexal Diseases, Adult Acute Lymphoblastic Leukemia in Remission, +221 more
Locations: Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

Dose Monitoring of Busulfan and Combination Chemotherapy in Hodgkin or Non-Hodgkin Lymphoma Undergoing Stem Cell Transplant

NCT01959477

Conditions: Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, +202 more
Locations: Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Palifermin in Preventing Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer

NCT01233921

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +151 more
Locations: Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

Rituximab Plus Interleukin-2 in Treating Patients With Hematologic Cancer

NCT00010192

Conditions: B-cell Adult Acute Lymphoblastic Leukemia, Burkitt Lymphoma, Chronic Disease, +82 more
Locations: Ohio State University Medical Center Columbus, Ohio, United States

View Trial Details

Completed

Alvocidib, Fludarabine Phosphate, and Rituximab in Treating Patients With Lymphoproliferative Disorders or Mantle Cell Lymphoma

NCT00058227

Conditions: B-cell Chronic Lymphocytic Leukemia, Blood Protein Disorders, Cardiovascular Diseases, +71 more
Locations: Ohio State University Medical Center Columbus, Ohio, United States

View Trial Details

Completed

Gossypol, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery

NCT00891072

Conditions: Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Blood Protein Disorders, +121 more
Locations: Cancer Institute of New Jersey New Brunswick, New Jersey, United States

View Trial Details

Completed

Monoclonal Antibody Therapy and Peripheral Stem Cell Transplant in Treating Patients With Non-Hodgkin's Lymphoma

NCT00017381

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +78 more
Locations: Johns Hopkins University Baltimore, Maryland, United States

View Trial Details

Noncontiguous Stage II Grade 1 Follicular Lymphoma

Noncontiguous Stage II Grade 1 Follicular Lymphoma trial results

Related conditions